Longevity Health Holdings, Inc. Market Cap ($420.80K)
Market Cap & Net Worth: Longevity Health Holdings, Inc. (XAGE)
Longevity Health Holdings, Inc. market cap. Longevity Health Holdings, Inc. (NASDAQ:XAGE) has a market capitalization of $420.80K ($420.80K) as of November 2, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #31134 globally and #6321 in its home market, demonstrating a -23.77% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Longevity Health Holdings, Inc.'s stock price $0.17 by its total outstanding shares 2475321 (2.48 Million). Also see Longevity Health Holdings, Inc. (XAGE) cash conversion ratio for how efficiently the company converts equity into cash flow.
Longevity Health Holdings, Inc. Market Cap History (2025–2026)
Longevity Health Holdings, Inc. market cap history from 2025 to 2026. Data shows growth from $744.82K to $420.80K (0.00% CAGR). Check today's stock price for Longevity Health Holdings, Inc. for real-time trading data and today's change.
Index Memberships
Longevity Health Holdings, Inc. is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.62 Trillion | 0.00% | #915 of 976 |
Weight: Longevity Health Holdings, Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Longevity Health Holdings, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Longevity Health Holdings, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Longevity Health Holdings, Inc. equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.39x
Longevity Health Holdings, Inc.'s market cap is 0.39 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $744.82K | $1.91 Million | -$6.91 Million | 0.39x | N/A |
Competitor Companies of XAGE by Market Capitalization
Companies near Longevity Health Holdings, Inc. in the global market cap rankings as of November 2, 2026. Also see how large is Longevity Health Holdings, Inc.'s balance sheet for a full breakdown of the balance sheet.
Key companies related to Longevity Health Holdings, Inc. by market ranking:
- Procter & Gamble Company (NYSE:PG): Ranked #40 globally with a market cap of $373.42 Billion USD.
- LOREAL ADR 1/5/EO 02 (F:LORA): Ranked #99 globally with a market cap of $204.17 Billion USD ( €174.64 Billion EUR).
- LOréal S.A. (PA:OR): Ranked #100 globally with a market cap of $204.16 Billion USD ( €174.63 Billion EUR).
- Unilever PLC (NASDAQ:UNLYD): Ranked #199 globally with a market cap of $120.76 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #40 | Procter & Gamble Company | NYSE:PG | $373.42 Billion | $161.57 |
| #99 | LOREAL ADR 1/5/EO 02 | F:LORA | $204.17 Billion | €72.00 |
| #100 | LOréal S.A. | PA:OR | $204.16 Billion | €436.95 |
| #199 | Unilever PLC | NASDAQ:UNLYD | $120.76 Billion | $55.38 |
Market Capitalization of Longevity Health Holdings, Inc. (2025–2026)
Market capitalization of Longevity Health Holdings, Inc. from 2025 to today. Between 2025 and today, Longevity Health Holdings, Inc.'s market cap moved from $744.82K to $ 420.80K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $420.80K | -43.50% |
| 2025 | $744.82K | -- |
End of Day Market Cap According to Different Sources
On Nov 2nd, 2026 the market cap of Longevity Health Holdings, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $420.80K USD |
| MoneyControl | $420.80K USD |
| MarketWatch | $420.80K USD |
| marketcap.company | $420.80K USD |
| Reuters | $420.80K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Longevity Health Holdings, Inc.
Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth fa… Read more